141 related articles for article (PubMed ID: 21206972)
1. Migration of renal tumor cells depends on dephosphorylation of Shc by PTEN.
Schneider E; Keppler R; Prawitt D; Steinwender C; Roos FC; Thüroff JW; Lausch E; Brenner W
Int J Oncol; 2011 Mar; 38(3):823-31. PubMed ID: 21206972
[TBL] [Abstract][Full Text] [Related]
2. In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself.
Breuksch I; Welter J; Bauer HK; Enklaar T; Frees S; Thüroff JW; Hasenburg A; Prawitt D; Brenner W
Cell Commun Signal; 2018 Jun; 16(1):35. PubMed ID: 29954386
[TBL] [Abstract][Full Text] [Related]
3. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
Wang H; Chen B; Duan B; Zheng J; Wu X
Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
[TBL] [Abstract][Full Text] [Related]
4. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
[TBL] [Abstract][Full Text] [Related]
5. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.
Sitaram RT; Cairney CJ; Grabowski P; Keith WN; Hallberg B; Ljungberg B; Roos G
Int J Cancer; 2009 Aug; 125(4):783-90. PubMed ID: 19384955
[TBL] [Abstract][Full Text] [Related]
6. Activation of PI3K is associated with reduced survival in renal cell carcinoma.
Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
[TBL] [Abstract][Full Text] [Related]
7. Relevance and therapeutic possibility of PTEN-long in renal cell carcinoma.
Wang H; Zhang P; Lin C; Yu Q; Wu J; Wang L; Cui Y; Wang K; Gao Z; Li H
PLoS One; 2015; 10(2):e114250. PubMed ID: 25714556
[TBL] [Abstract][Full Text] [Related]
8. Bone Metastasis in Renal Cell Carcinoma is Preprogrammed in the Primary Tumor and Caused by AKT and Integrin α5 Signaling.
Haber T; Jöckel E; Roos FC; Junker K; Prawitt D; Hampel C; Thüroff JW; Brenner W;
J Urol; 2015 Aug; 194(2):539-46. PubMed ID: 25623744
[TBL] [Abstract][Full Text] [Related]
9. Cordycepin induces apoptotic cell death and inhibits cell migration in renal cell carcinoma via regulation of microRNA-21 and PTEN phosphatase.
Yang C; Zhao L; Yuan W; Wen J
Biomed Res; 2017; 38(5):313-320. PubMed ID: 29070781
[TBL] [Abstract][Full Text] [Related]
10. Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated PTEN Expression.
Kalogirou C; Schäfer D; Krebs M; Kurz F; Schneider A; Riedmiller H; Kneitz B; Vergho D
Urol Int; 2016; 96(1):106-15. PubMed ID: 26496641
[TBL] [Abstract][Full Text] [Related]
11. [Non-metastatic clear cell renal carcinoma: prognostic significance of morphometric and biomolecular factors].
Iurin AG
Vopr Onkol; 2009; 55(2):177-82. PubMed ID: 19514371
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
13. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
14. The mammalian target of rapamycin pathway is widely activated without PTEN deletion in renal cell carcinoma metastases.
Abou Youssif T; Fahmy MA; Koumakpayi IH; Ayala F; Al Marzooqi S; Chen G; Tamboli P; Squire J; Tanguay S; Sircar K
Cancer; 2011 Jan; 117(2):290-300. PubMed ID: 20830770
[TBL] [Abstract][Full Text] [Related]
15. Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.
Chen J; Zhu H; Zhang Y; Cui MH; Han LY; Jia ZH; Wang L; Teng H; Miao LN
Mol Med Rep; 2015 Aug; 12(2):2622-8. PubMed ID: 25954860
[TBL] [Abstract][Full Text] [Related]
16. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.
Pantuck AJ; Seligson DB; Klatte T; Yu H; Leppert JT; Moore L; O'Toole T; Gibbons J; Belldegrun AS; Figlin RA
Cancer; 2007 Jun; 109(11):2257-67. PubMed ID: 17440983
[TBL] [Abstract][Full Text] [Related]
18. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN.
Fan W; Huang J; Xiao H; Liang Z
Mol Med Rep; 2016 Jun; 13(6):4800-6. PubMed ID: 27082730
[TBL] [Abstract][Full Text] [Related]
20. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
